Abstract
Host reactivity to biocompatible immunoisolation devices is a major challenge for cellular therapies, and a human screening model would be of great value. We designed new types of surface modified barium alginate microspheres, and evaluated their inflammatory properties using human whole blood, and the intraperitoneal response after three weeks in Wistar rats. Microspheres were modified using proprietary polyallylamine (PAV) and coupled with macromolecular heparin conjugates (Corline Heparin Conjugate, CHC). The PAV-CHC strategy resulted in uniform and stable coatings with increased anti-clot activity and low cytotoxicity. In human whole blood, PAV coating at high dose (100 µg/ml) induced elevated complement, leukocyte CD11b and inflammatory mediators, and in Wistar rats increased fibrotic overgrowth. Coating of high dose PAV with CHC significantly reduced these responses. Low dose PAV (10 µg/ml) ± CHC and unmodified alginate microbeads showed low responses. That the human whole blood inflammatory reactions paralleled the host response shows a link between inflammatory potential and initial fibrotic response. CHC possessed anti-inflammatory activity, but failed to improve overall biocompatibility. We conclude that the human whole blood assay is an efficient first-phase screening model for inflammation, and a guiding tool in development of new generation microspheres for cell encapsulation therapy.
Highlights
Despite several years of research employing different strategies[4,5,6,7,8,9,10,11], a truly biocompatible microsphere devoid of PFO upon implantation is hard to develop
confocal laser scanning microscopy (CLSM) images demonstrated that using PAV at both 100 and 10 μg/ml, a uniform coating of Corline Heparin Conjugates (CHC) could be established on the surface of alginate microbeads (Fig. 1A and B)
Our study addressed the above issues by new microspheres design using PAV and CHC, secondly determining the inflammatory potential using a human whole blood model, and verifying to the host response in an immunocompetent rat model
Summary
Despite several years of research employing different strategies[4,5,6,7,8,9,10,11], a truly biocompatible microsphere devoid of PFO upon implantation is hard to develop. PFO is a complex process and involves various factors such as protein adsorption, leukocyte activation and granulation formation consisting of fibroblasts and macrophages[12]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
